{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:03:00Z","timestamp":1791932580657,"version":"4.3.4"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Acute rejection (AR) remains a major determinant of renal allograft outcomes, with the major histocompatibility complex (MHC) playing a pivotal role in its pathogenesis. Although immunosuppressive therapies have advanced, their reliance on high doses and lifelong administration increases the risks of infections, malignancies, and other serious complications. Normothermic machine perfusion (NMP) has emerged as a valuable tool in clinical transplantation, enabling organ preservation, functional assessment, and therapeutic intervention. Integrating NMP with genetic engineering approaches to modulate donor kidney MHC expression may offer a novel strategy for preventing AR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      We synthesized cholesterol-modified small interfering RNA targeting\n                      <jats:italic toggle=\"yes\">B2m<\/jats:italic>\n                      and Ciita (si\n                      <jats:italic toggle=\"yes\">B2m<\/jats:italic>\n                      -Chol and\n                      <jats:italic toggle=\"yes\">siCiita<\/jats:italic>\n                      -Chol) and set cholesterol-modified negative control small interfering RNA (siNC-Chol) as control. Interfering with MHC expression in transplanted kidneys using NMP combined with siB2m-Chol and siCiita-Chol pretreatment of donor kidneys to prevent AR of posttransplant allografts, we evaluated the efficacy of this approach by assessing postoperative survival, renal function, histological features, and inflammatory responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>NMP combined with siB2m-Chol and siCiita-Chol significantly reduced MHC expression on postoperative day 3, improved allograft function, and prolonged recipient survival. By postoperative day 7, pathological damage was reduced, and T cells, macrophages, B cells, donor-specific antibodies, and inflammatory cytokine production were markedly lower in treated grafts compared with the siNC-Chol control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>These findings demonstrate that ex vivo NMP effectively delivers cholesterol-modified small interfering RNA to renal grafts, substantially downregulating both MHC class I and II expression and consequently attenuating AR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005529","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:20:29Z","timestamp":1761625229000},"page":"e154-e165","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Normothermic Machine Perfusion Combined With Modified Small Interfering RNA Targeting Beta-2-microglobulin and Class II Major Histocompatibility Complex Transactivator Mitigates Acute Rejection of Renal Allograft"],"prefix":"10.1097","volume":"110","author":[{"given":"Li","family":"Lin","sequence":"first","affiliation":[{"name":"Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[{"name":"Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangjin","family":"Yu","sequence":"additional","affiliation":[{"name":"Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixin","family":"Lan","sequence":"additional","affiliation":[{"name":"Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tao","sequence":"additional","affiliation":[{"name":"Nanchang Research Institute, Sun Yat-sen University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Qiu","sequence":"additional","affiliation":[{"name":"Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China."},{"name":"Nanchang Research Institute, Sun Yat-sen University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM199408113310606","article-title":"Renal transplantation.","volume":"331","author":"Suthanthiran","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report\u20142011.","volume":"30","author":"Stehlik","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 1","key":"R3-20260119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: kidney.","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transplant"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.healun.2009.08.014","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report\u20142009.","volume":"28","author":"Taylor","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.transproceed.2008.07.004","article-title":"Impact of Banff borderline acute rejection among renal allograft recipients.","volume":"40","author":"Matoza","year":"2008","journal-title":"Transplant Proc"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1681\/ASN.V8121930","article-title":"Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation.","volume":"8","author":"Colvin","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.94.2.695","article-title":"Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.","volume":"94","author":"Strehlau","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00007890-199608150-00017","article-title":"Human heart endothelial-cell-restricted allorecognition.","volume":"62","author":"Jutte","year":"1996","journal-title":"Transplantation"},{"key":"R9-20260119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fimmu.2020.00265","article-title":"Genetic engineering of the kidney to permanently silence MHC transcripts during ex vivo organ perfusion.","volume":"11","author":"Yuzefovych","year":"2020","journal-title":"Front Immunol"},{"key":"R10-20260119","first-page":"420","article-title":"Prolongation of allogenic rat renal graft survival after perfusion the organ with anti-MHC class II antibody.","volume":"53","author":"Oko","year":"1996","journal-title":"Przegl Lek"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1034\/j.1600-6143.2001.001003211.x","article-title":"The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney.","volume":"1","author":"Sims","year":"2001","journal-title":"Am J Transplant"},{"key":"R12-20260119","first-page":"1473","article-title":"Immune status and risk for infection in patients receiving chronic immunosuppressive therapy.","volume":"32","author":"Gl\u00fcck","year":"2005","journal-title":"J Rheumatol"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ckj\/sfx122","article-title":"Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network.","volume":"11","author":"Sprangers","year":"2018","journal-title":"Clin Kidney J"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.13778","article-title":"Past, present, and future of dynamic kidney and liver preservation and resuscitation.","volume":"16","author":"Jochmans","year":"2016","journal-title":"Am J Transplant"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/jcm9030879","article-title":"Kidney perfusion as an organ quality assessment tool\u2014are we counting our chickens before they have hatched?","volume":"9","author":"De Beule","year":"2020","journal-title":"J Clin Med"},{"key":"R16-20260119","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/bjs.5909","article-title":"Experimental renal preservation by normothermic resuscitation perfusion with autologous blood.","volume":"95","author":"Bagul","year":"2008","journal-title":"Br J Surg"},{"key":"R17-20260119","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1097\/TXD.0000000000000944","article-title":"Brief normothermic machine perfusion rejuvenates discarded human kidneys.","volume":"5","author":"Hameed","year":"2019","journal-title":"Transplant Direct"},{"key":"R18-20260119","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-018-0039-x","article-title":"HLA in transplantation.","volume":"14","author":"Montgomery","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"R19-20260119","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/tri.13441","article-title":"The future of organ perfusion and re-conditioning.","volume":"32","author":"Weissenbacher","year":"2019","journal-title":"Transplant Int"},{"key":"R20-20260119","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/TXD.0000000000000655","article-title":"Lowering perfusate temperature from 37\u00b0C to 32\u00b0C diminishes function in a porcine model of ex vivo kidney perfusion.","volume":"3","author":"Adams","year":"2017","journal-title":"Transplant Direct"},{"key":"R21-20260119","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jconrel.2019.10.046","article-title":"Polymeric siRNA gene delivery\u2014transfection efficiency versus cytotoxicity.","volume":"316","author":"Kargaard","year":"2019","journal-title":"J Control Release"},{"key":"R22-20260119","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0030-1255448","article-title":"Thrombotic complications of erythropoiesis-stimulating agents.","volume":"36","author":"Lippi","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"R23-20260119","doi-asserted-by":"crossref","first-page":"174178","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: Mechanism of action, challenges, and therapeutic approaches.","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"R24-20260119","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.4049\/jimmunol.174.4.2116","article-title":"Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules.","volume":"174","author":"Berko","year":"2005","journal-title":"J Immunol"},{"key":"R25-20260119","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/ijms22031074","article-title":"The MHC class II transactivator CIITA: not (quite) the odd-one-out anymore among NLR proteins.","volume":"22","author":"Leon Machado","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R26-20260119","doi-asserted-by":"crossref","first-page":"1404668","DOI":"10.3389\/fimmu.2024.1404668","article-title":"Heart immunoengineering by lentiviral vector-mediated genetic modification during normothermic ex vivo perfusion.","volume":"15","author":"Schmalkuche","year":"2024","journal-title":"Front Immunol"},{"key":"R27-20260119","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"R28-20260119","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"R29-20260119","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10555-017-9717-6","article-title":"RNA interference-based therapy and its delivery systems.","volume":"37","author":"Chen","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"R30-20260119","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.omtn.2022.12.008","article-title":"Chemically modified small interfering RNA targeting Hedgehog signaling pathway for rheumatoid arthritis therapy.","volume":"31","author":"Lin","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"R31-20260119","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41388-021-02140-6","article-title":"FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression.","volume":"41","author":"Guo","year":"2022","journal-title":"Oncogene"},{"key":"R32-20260119","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection.","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"R33-20260119","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/ajt.14602","article-title":"Triptolide inhibits donor-specific antibody production and attenuates mixed antibody-mediated renal allograft injury.","volume":"18","author":"Zhao","year":"2018","journal-title":"Am J Transplant"},{"key":"R34-20260119","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-019-1142-y","article-title":"Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma.","volume":"38","author":"Xiang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"R35-20260119","doi-asserted-by":"crossref","first-page":"e2835","DOI":"10.1038\/cddis.2017.230","article-title":"RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion.","volume":"8","author":"Xu","year":"2017","journal-title":"Cell Death Dis"},{"key":"R36-20260119","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13613-024-01342-x","article-title":"Urine output is an early and strong predictor of acute kidney injury and associated mortality: a systematic literature review of 50 clinical studies.","volume":"14","author":"Malbrain","year":"2024","journal-title":"Ann Intensive Care"},{"key":"R37-20260119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/019262339802600105","article-title":"In vitro methods of assessing renal damage.","volume":"26","author":"Lash","year":"1998","journal-title":"Toxicol Pathol"},{"key":"R38-20260119","doi-asserted-by":"crossref","first-page":"100585","DOI":"10.1016\/j.trre.2020.100585","article-title":"Organ donation in the US and Europe: the supply vs demand imbalance.","volume":"35","author":"Lewis","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"R39-20260119","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.","volume":"388","author":"Thomusch","year":"2016","journal-title":"Lancet"},{"key":"R40-20260119","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MOT.0000000000001141","article-title":"Normothermic machine perfusion for liver transplantation: current state and future directions.","volume":"29","author":"Lindemann","year":"2024","journal-title":"Curr Opin Organ Transplant"},{"key":"R41-20260119","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/ajt.12179","article-title":"Renal transplantation after ex vivo normothermic perfusion: the first clinical study.","volume":"13","author":"Nicholson","year":"2013","journal-title":"Am J Transplant"},{"key":"R42-20260119","doi-asserted-by":"crossref","first-page":"785","DOI":"10.21037\/hbsn-23-180","article-title":"The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution.","volume":"12","author":"Liang","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R43-20260119","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ekir.2016.07.009","article-title":"Ex vivo normothermic perfusion induces donor-derived leukocyte mobilization and removal prior to renal transplantation.","volume":"1","author":"Stone","year":"2016","journal-title":"Kidney Int Rep"},{"key":"R44-20260119","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/hum.2018.117","article-title":"Immunoengineering of the vascular endothelium to silence MHC expression during normothermic ex vivo lung perfusion.","volume":"30","author":"Figueiredo","year":"2019","journal-title":"Hum Gene Ther"},{"key":"R45-20260119","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/hum.2016.070","article-title":"Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model.","volume":"28","author":"Machuca","year":"2017","journal-title":"Hum Gene Ther"},{"key":"R46-20260119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000004573","article-title":"Normothermic machine perfusion systems: where do we go from here?","volume":"108","author":"L\u00f3pez-Mart\u00ednez","year":"2024","journal-title":"Transplantation"},{"key":"R47-20260119","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1093\/nar\/gky745","article-title":"Functional features defining the efficacy of cholesterol-conjugated, self-deliverable, chemically modified siRNAs.","volume":"46","author":"Shmushkovich","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"R48-20260119","doi-asserted-by":"crossref","first-page":"e85293","DOI":"10.1172\/jci.insight.85293","article-title":"Blocking MHC class II on human endothelium mitigates acute rejection.","volume":"1","author":"Abrahimi","year":"2016","journal-title":"JCI Insight"},{"key":"R49-20260119","doi-asserted-by":"crossref","first-page":"155705","DOI":"10.1016\/j.cyto.2021.155705","article-title":"Cytokines in liver transplantation.","volume":"148","author":"Assadiasl","year":"2021","journal-title":"Cytokine"},{"issue":"Suppl 4","key":"R50-20260119","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.17207","article-title":"Importance of IL-6 inhibition in prevention and treatment of antibody-mediated rejection in kidney allografts.","volume":"22","author":"Jordan","year":"2022","journal-title":"Am J Transplant"},{"key":"R51-20260119","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2215\/CJN.00700117","article-title":"Donor-specific antibodies in kidney transplant recipients.","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R52-20260119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2007.03.005","article-title":"RNAi therapeutics: principles, prospects and challenges.","volume":"59","author":"Aagaard","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"4S1 Suppl 1","key":"R53-20260119","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation.","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"R54-20260119","doi-asserted-by":"crossref","first-page":"10301","DOI":"10.3390\/ijms241210301","article-title":"Current status regarding immunosuppressive treatment in patients after renal transplantation.","volume":"24","author":"Szumilas","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:00:25Z","timestamp":1768834825000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005529","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}